Pontzer, H., Wood, B. M. & Raichlen, D. A. Hunter-gatherers as models in public health. Obes. Rev. 19, 24–35 (2018).
Sonnenburg, J. L. & Sonnenburg, E. D. Vulnerability of the industrialized microbiota. Science 366, eaaw9255 (2019).
Kenyon, C. J. The genetics of ageing. Nature 464, 504–512 (2010).
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
Wilson, K. A. et al. Evaluating the beneficial effects of dietary restrictions: a framework for precision nutrigeroscience. Cell Metab. 33, 2142–2173 (2021).
Rodgers, G. P. & Collins, F. S. Precision nutrition-the answer to “what to eat to stay healthy”. JAMA 324, 735–736 (2020).
Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183–203 (2020).
Szwed, A., Kim, E. & Jacinto, E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol. Rev. 101, 1371–1426 (2021).
Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).
Dorling, J. L., Martin, C. K. & Redman, L. M. Calorie restriction for enhanced longevity: the role of novel dietary strategies in the present obesogenic environment. Ageing Res. Rev. 64, 101038 (2020).
Sowah, S. A. et al. Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial. Genome Med. 14, 30 (2022).
O’Flanagan, C. H., Smith, L. A., McDonell, S. B. & Hursting, S. D. When less may be more: calorie restriction and response to cancer therapy. BMC Med. 15, 106 (2017).
Madeo, F., Carmona-Gutierrez, D., Hofer, S. J. & Kroemer, G. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential. Cell Metab. 29, 592–610 (2019).
Chong, C. R., Sallustio, B. & Horowitz, J. D. Drugs that affect cardiac metabolism: focus on perhexiline. Cardiovasc Drugs Ther. 30, 399–405 (2016).
Schreiber, K. H. et al. A novel rapamycin analog is highly selective for mTORC1 in vivo. Nat. Commun. 10, 3194 (2019).
Lamming, D. W. et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638–1643 (2012).
Sarbassov, D. D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159–168 (2006).
González, A., Hall, M. N., Lin, S. C. & Hardie, D. G. AMPK and TOR: the yin and yang of cellular nutrient sensing and growth control. Cell Metab. 31, 472–492 (2020).
Lin, S. C. & Hardie, D. G. AMPK: sensing glucose as well as cellular energy status. Cell Metab. 27, 299–313 (2018).
Fontana, L. & Partridge, L. Promoting health and longevity through diet: from model organisms to humans. Cell 161, 106–118 (2015).
Kapahi, P., Kaeberlein, M. & Hansen, M. Dietary restriction and lifespan: lessons from invertebrate models. Ageing Res. Rev. 39, 3–14 (2017).
Schulz, T. J. et al. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 6, 280–293 (2007).
Ristow, M. & Zarse, K. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 45, 410–418 (2010).
Weir, H. J. et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab. 26, 884–896.e5 (2017).
Boccardi, V., Murasecco, I. & Mecocci, P. Diabetes drugs in the fight against Alzheimer’s disease. Ageing Res. Rev. 54, 100936 (2019).
Calissi, G., Lam, E. W. & Link, W. Therapeutic strategies targeting FOXO transcription factors. Nat. Rev. Drug Disco. 20, 21–38 (2021).
Greer, E. L. & Brunet, A. Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell 8, 113–127 (2009).
Giannakou, M. E., Goss, M. & Partridge, L. Role of dFOXO in lifespan extension by dietary restriction in Drosophila melanogaster: not required, but its activity modulates the response. Aging Cell 7, 187–198 (2008).
Miyauchi, T. et al. Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury. Proc. Natl Acad. Sci. USA 116, 13533–13542 (2019).
Furuyama, T. et al. Effects of aging and caloric restriction on the gene expression of Foxo1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles. Microsc. Res. Tech. 59, 331–334 (2002).
Shimokawa, I. et al. The life-extending effect of dietary restriction requires Foxo3 in mice. Aging Cell 14, 707–709 (2015).
Xia, Y. et al. Neuronal C/EBPβ/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression. Sci. Adv. 8, eabj8658 (2022).
Zhu, S. et al. The roles of sirtuins family in cell metabolism during tumor development. Semin. Cancer Biol. 57, 59–71 (2019).
Xie, N. et al. NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target Ther. 5, 227 (2020).
Covarrubias, A. J., Perrone, R., Grozio, A. & Verdin, E. NAD(+) metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 22, 119–141 (2021).
Lin, S. J., Defossez, P. A. & Guarente, L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126–2128 (2000).
Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225–238 (2012).
Cohen, H. Y. et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390–392 (2004).
Han, X. et al. Targeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy. Pharm. Ther. 229, 107983 (2022).
Civitarese, A. E. et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 4, e76 (2007).
Gomes, P. et al. The yin and yang faces of the mitochondrial deacetylase sirtuin 3 in age-related disorders. Ageing Res. Rev. 57, 100983 (2020).
Nakagawa, T., Lomb, D. J., Haigis, M. C. & Guarente, L. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560–570 (2009).
Bordone, L. et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6, 759–767 (2007).
Herranz, D. et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun. 1, 3 (2010).
North, B. J. et al. SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J. 33, 1438–1453 (2014).
Benigni, A. et al. Sirt3 deficiency shortens life span and impairs cardiac mitochondrial function rescued by Opa1 gene transfer. Antioxid. Redox Signal 31, 1255–1271 (2019).
Brown, K. et al. SIRT3 reverses aging-associated degeneration. Cell Rep. 3, 319–327 (2013).
Kawahara, T. L. et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136, 62–74 (2009).
Vakhrusheva, O. et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703–710 (2008).
Korotkov, A., Seluanov, A. & Gorbunova, V. Sirtuin 6: linking longevity with genome and epigenome stability. Trends Cell Biol. 31, 994–1006 (2021).
Sun, S. et al. Vascular endothelium-targeted Sirt7 gene therapy rejuvenates blood vessels and extends life span in a Hutchinson-Gilford progeria model. Sci. Adv. 6, eaay5556 (2020).
Berdichevsky, A., Viswanathan, M., Horvitz, H. R. & Guarente, L. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 125, 1165–1177 (2006).
Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011–2015 (2004).
Wang, R. et al. Metabolic stress modulates Alzheimer’s β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons. Cell Metab. 17, 685–694 (2013).
Cantó, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056–1060 (2009).
Someya, S. et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802–812 (2010).
Hebert, A. S. et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186–199 (2013).
Van Meter, M. et al. JNK phosphorylates SIRT6 to stimulate DNA double-strand break repair in response to oxidative stress by recruiting PARP1 to DNA breaks. Cell Rep. 16, 2641–2650 (2016).
Simon, M. et al. LINE1 derepression in aged wild-type and SIRT6-deficient mice drives inflammation. Cell Metab. 29, 871–885.e5 (2019).
Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O. & Sinclair, D. A. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423, 181–185 (2003).
Moroz, N. et al. Dietary restriction involves NAD+-dependent mechanisms and a shift toward oxidative metabolism. Aging Cell 13, 1075–1085 (2014).
Covarrubias, A. J. et al. Senescent cells promote tissue NAD(+) decline during ageing via the activation of CD38(+) macrophages. Nat. Metab. 2, 1265–1283 (2020).
Yoshida, M. et al. Extracellular vesicle-contained eNAMPT delays aging and extends lifespan in mice. Cell Metab. 30, 329–342.e5 (2019).
Ramsey, K. M. et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651–654 (2009).
Yoshino, M. et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 372, 1224–1229 (2021).
Levine, D. C. et al. NAD(+) controls circadian reprogramming through PER2 nuclear translocation to counter aging. Mol. Cell 78, 835–849.e7 (2020).
Hou, Y. et al. NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer’s disease via cGAS-STING. Proc. Natl Acad. Sci. USA 118, e2011226118 (2021).
Killilea, D. W. & Killilea, A. N. Mineral requirements for mitochondrial function: a connection to redox balance and cellular differentiation. Free Radic. Biol. Med. 182, 182–191 (2022).
Wawrzyniak, N. & Suliburska, J. Nutritional and health factors affecting the bioavailability of calcium: a narrative review. Nutr. Rev. 79, 1307–1320 (2021).
Dominguez, L., Veronese, N. & Barbagallo, M. Magnesium and hypertension in old age. Nutrients 13, 139 (2020).
Mohammadifard, N. et al. Trace minerals intake: risks and benefits for cardiovascular health. Crit. Rev. Food Sci. Nutr. 59, 1334–1346 (2019).
Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254–1261 (2022).
Donadio, J. L. S., Duarte, G. B. S., Borel, P., Cozzolino, S. M. F. & Rogero, M. M. The influence of nutrigenetics on biomarkers of selenium nutritional status. Nutr. Rev. 79, 1259–1273 (2021).
Custers, E., Kiliaan, E. M. & Amanda, J. Dietary lipids from body to brain. Prog. Lipid Res. 85, 101144 (2022).
Katewa, S. D. et al. Intramyocellular fatty-acid metabolism plays a critical role in mediating responses to dietary restriction in Drosophila melanogaster. Cell Metab. 16, 97–103 (2012).
Bruss, M. D., Khambatta, C. F., Ruby, M. A., Aggarwal, I. & Hellerstein, M. K. Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. Am. J. Physiol. Endocrinol. Metab. 298, E108–E116 (2010).
Picard, F. et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771–776 (2004).
Indraccolo, S. et al. Phosphorylated acetyl-CoA carboxylase is associated with clinical benefit with regorafenib in relapsed glioblastoma: REGOMA trial biomarker analysis. Clin. Cancer Res. 26, 4478–4484 (2020).
Marcellino, B. K., Ekasumara, N. & Mobbs, C. V. Dietary restriction and glycolytic inhibition reduce proteotoxicity and extend lifespan via NHR-49. Curr. Neurobiol. 9, 1–7 (2018).
Stekovic, S. et al. Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans. Cell Metab. 30, 462–476.e6 (2019).
Kolb, H. et al. Ketone bodies: from enemy to friend and guardian angel. BMC Med. 19, 313 (2021).
Chamoli, M. et al. Polyunsaturated fatty acids and p38-MAPK link metabolic reprogramming to cytoprotective gene expression during dietary restriction. Nat. Commun. 11, 4865 (2020).
Le Couteur, D. G. et al. Branched chain amino acids, aging and age-related health. Ageing Res. Rev. 64, 101198 (2020).
Matai, L. et al. Dietary restriction improves proteostasis and increases life span through endoplasmic reticulum hormesis. Proc. Natl Acad. Sci. USA 116, 17383–17392 (2019).
Ferro-Novick, S., Reggiori, F. & Brodsky, J. L. ER-phagy, ER homeostasis, and ER quality control: implications for disease. Trends Biochem. Sci. 46, 630–639 (2021).
Levine, B. & Kroemer, G. Biological functions of autophagy genes: a disease perspective. Cell 176, 11–42 (2019).
Ulgherait, M. et al. Circadian autophagy drives iTRF-mediated longevity. Nature 598, 353–358 (2021).
Hansen, M., Rubinsztein, D. C. & Walker, D. W. Autophagy as a promoter of longevity: insights from model organisms. Nat. Rev. Mol. Cell Biol. 19, 579–593 (2018).
Jung, Y. et al. MON-2, a Golgi protein, mediates autophagy-dependent longevity in Caenorhabditis elegans. Sci. Adv. 7, eabj8156 (2021).
Pietrocola, F. et al. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell 30, 147–160 (2016).
Saito, T. et al. Autophagy regulates lipid metabolism through selective turnover of NCoR1. Nat. Commun. 10, 1567 (2019).
Jouandin, P. et al. Lysosomal cystine mobilization shapes the response of TORC1 and tissue growth to fasting. Science 375, eabc4203 (2022).
Green, C. L., Lamming, D. W. & Fontana, L. Molecular mechanisms of dietary restriction promoting health and longevity. Nat. Rev. Mol. Cell Biol. 23, 56–73 (2022).
Sutter, B. M., Wu, X., Laxman, S. & Tu, B. P. Methionine inhibits autophagy and promotes growth by inducing the SAM-responsive methylation of PP2A. Cell 154, 403–415 (2013).
White, E., Lattime, E. C. & Guo, J. Y. Autophagy regulates stress responses, metabolism, and anticancer immunity. Trends Cancer 7, 778–789 (2021).
Ouyang, Y., Wu, Q., Li, J., Sun, S. & Sun, S. S-adenosylmethionine: a metabolite critical to the regulation of autophagy. Cell Prolif. 53, e12891 (2020).
Falcón, P., Escandón, M., Brito, Á. & Matus, S. Nutrient sensing and redox balance: GCN2 as a new integrator in aging. Oxid. Med. Cell Longev. 2019, 5730532 (2019).
Laeger, T. et al. Metabolic responses to dietary protein restriction require an increase in FGF21 that is delayed by the absence of GCN2. Cell Rep. 16, 707–716 (2016).
Amorim, J. A. et al. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat. Rev. Endocrinol. 18, 243–258 (2022).
Spadaro, O. et al. Caloric restriction in humans reveals immunometabolic regulators of health span. Science 375, 671–677 (2022).
Qiu, X., Brown, K., Hirschey, M. D., Verdin, E. & Chen, D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 12, 662–667 (2010).
López-Lluch, G. et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl Acad. Sci. USA 103, 1768–1773 (2006).
Lanza, I. R. et al. Chronic caloric restriction preserves mitochondrial function in senescence without increasing mitochondrial biogenesis. Cell Metab. 16, 777–788 (2012).
Song, J., Herrmann, J. M. & Becker, T. Quality control of the mitochondrial proteome. Nat. Rev. Mol. Cell Biol. 22, 54–70 (2021).
Ruan, L. et al. Mitochondria-associated proteostasis. Annu. Rev. Biophys. 49, 41–67 (2020).
Ozkurede, U. & Miller, R. A. Improved mitochondrial stress response in long-lived Snell dwarf mice. Aging Cell 18, e13030 (2019).
Durieux, J., Wolff, S. & Dillin, A. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144, 79–91 (2011).
Lam, J. & McKeague, M. Dietary modulation of mitochondrial DNA damage: implications in aging and associated diseases. J. Nutr. Biochem 63, 1–10 (2019).
Mehrabani, S., Bagherniya, M., Askari, G., Read, M. I. & Sahebkar, A. The effect of fasting or calorie restriction on mitophagy induction: a literature review. J. Cachexia Sarcopenia Muscle 11, 1447–1458 (2020).
Gyanwali, B. et al. Alpha-Ketoglutarate dietary supplementation to improve health in humans. Trends Endocrinol. Metab. 33, 136–146 (2022).
Campbell, S. L. & Wellen, K. E. Metabolic signaling to the nucleus in cancer. Mol. Cell 71, 398–408 (2018).
Diehl, K. L. & Muir, T. W. Chromatin as a key consumer in the metabolite economy. Nat. Chem. Biol. 16, 620–629 (2020).
Zheng, Y. & Cantley, L. C. Toward a better understanding of folate metabolism in health and disease. J. Exp. Med. 216, 253–266 (2019).
Kottakis, F. et al. LKB1 loss links serine metabolism to DNA methylation and tumorigenesis. Nature 539, 390–395 (2016).
Wu, Q., Chen, X., Li, J. & Sun, S. Serine and metabolism regulation: a novel mechanism in antitumor immunity and senescence. Aging Dis. 11, 1640–1653 (2020).
Morris, J. P. T. et al. α-Ketoglutarate links p53 to cell fate during tumour suppression. Nature 573, 595–599 (2019).
Parkhitko, A. A., Jouandin, P., Mohr, S. E. & Perrimon, N. Methionine metabolism and methyltransferases in the regulation of aging and lifespan extension across species. Aging Cell 18, e13034 (2019).
Mota-Martorell, N. et al. Methionine transsulfuration pathway is upregulated in long-lived humans. Free Radic. Biol. Med. 162, 38–52 (2021).
Sun, L., Zhang, H. & Gao, P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. https://doi.org/10.1007/s13238-021-00846-7 (2021).
Lim, C. Y. et al. SAMS-1 coordinates HLH-30/TFEB and PHA-4/FOXA activities through histone methylation to mediate dietary restriction-induced autophagy and longevity. Autophagy 3, 1–17 (2022).
Wang, Y. et al. Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations. Nat. Commun. 11, 5596 (2020).
Sen, P. et al. Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence. Mol. Cell 73, 684–698 e8 (2019).
Morselli, E. et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 1, e10 (2010).
Pietrocola, F. et al. Aspirin recapitulates features of caloric restriction. Cell Rep. 22, 2395–2407 (2018).
Madeo, F., Eisenberg, T., Pietrocola, F. & Kroemer, G. Spermidine in health and disease. Science 359, eaan2788 (2018).
Smestad, J., Erber, L., Chen, Y. & Maher, L. J. 3rd Chromatin succinylation correlates with active gene expression and is perturbed by defective TCA cycle metabolism. iScience 2, 63–75 (2018).
Li, L. et al. SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability. Nat. Commun. 7, 12235 (2016).
Goodall, G. J. & Wickramasinghe, V. O. RNA in cancer. Nat. Rev. Cancer 21, 22–36 (2021).
Victoria, B., Nunez Lopez, Y. O. & Masternak, M. M. MicroRNAs and the metabolic hallmarks of aging. Mol. Cell Endocrinol. 455, 131–147 (2017).
Cardoso, A. L. et al. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res. Rev. 47, 214–277 (2018).
Caravia, X. M., Roiz-Valle, D., Morán-Álvarez, A. & López-Otín, C. Functional relevance of miRNAs in premature ageing. Mech. Ageing Dev. 168, 10–19 (2017).
Victoria, B. et al. Circulating microRNA signature of genotype-by-age interactions in the long-lived Ames dwarf mouse. Aging Cell 14, 1055–1066 (2015).
Csiszar, A. et al. Caloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats. Am. J. Physiol. Heart Circ. Physiol. 307, H292–H306 (2014).
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B. & Kahn, C. R. Extracellular miRNAs: from biomarkers to mediators of physiology and disease. Cell Metab. 30, 656–673 (2019).
Kumar, S., Vijayan, M., Bhatti, J. S. & Reddy, P. H. MicroRNAs as peripheral biomarkers in aging and age-related diseases. Prog. Mol. Biol. Transl. Sci. 146, 47–94 (2017).
Jia, M. et al. Cross-kingdom regulation by dietary plant miRNAs: an evidence-based review with recent updates. Food Funct. 12, 9549–9562 (2021).
Wu, Q. et al. Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy. Cell Death Dis. 11, 1015 (2020).
Wu, Q. et al. IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms. J. Immunother. Cancer 9, e002722 (2021).
Ouyang, Y. et al. Chalcone derivatives: role in anticancer therapy. Biomolecules 11, 894 (2021).
Chen, G. et al. 3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and TFEB. EMBO Mol. Med 11, e10469 (2019).
Carmona-Gutierrez, D. et al. The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species. Nat. Commun. 10, 651 (2019).
Reinke, H. & Asher, G. Crosstalk between metabolism and circadian clocks. Nat. Rev. Mol. Cell Biol. 20, 227–241 (2019).
Rijo-Ferreira, F. & Takahashi, J. S. Genomics of circadian rhythms in health and disease. Genome Med 11, 82 (2019).
Frazier, K. et al. High-fat diet disrupts REG3γ and gut microbial rhythms promoting metabolic dysfunction. Cell Host Microbe 30, 809–823.e6 (2022).
Acosta-Rodríguez, V. et al. Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice. Science 376, 1192–1202 (2022).
Katewa, S. D. et al. Peripheral circadian clocks mediate dietary restriction-dependent changes in lifespan and fat metabolism in Drosophila. Cell Metab. 23, 143–154 (2016).
Xie, Z. et al. Randomized controlled trial for time-restricted eating in healthy volunteers without obesity. Nat. Commun. 13, 1003 (2022).
Levine, D. C. et al. NADH inhibition of SIRT1 links energy state to transcription during time-restricted feeding. Nat. Metab. 3, 1621–1632 (2021).
Patke, A., Young, M. W. & Axelrod, S. Molecular mechanisms and physiological importance of circadian rhythms. Nat. Rev. Mol. Cell Biol. 21, 67–84 (2020).
Chellappa, S. L. et al. Daytime eating prevents internal circadian misalignment and glucose intolerance in night work. Sci. Adv. 7, eabg9910 (2021).
Ulgherait, M. et al. Circadian regulation of mitochondrial uncoupling and lifespan. Nat. Commun. 11, 1927 (2020).
Tacad, D. K. M. et al. Satiety associated with calorie restriction and time-restricted feeding: peripheral hormones. Adv. Nutr. 13, 792–820 (2022).
López-Otín, C. & Kroemer, G. Hallmarks of Health. Cell 184, 33–63 (2021).
Cignarella, F. et al. Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metab. 27, 1222–1235 e6 (2018).
Bravo-San Pedro, J. M. et al. Acyl-CoA-binding protein is a lipogenic factor that triggers food intake and obesity. Cell Metab. 30, 754–767.e9 (2019).
Mishra, I. et al. Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor. Cell Metab. 34, 549–563.e8 (2022).
Clancy, D. J. et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104–106 (2001).
Tatar, M. et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107–110 (2001).
Caffa, I. et al. Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 583, 620–624 (2020).
Pollak, M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer 12, 159–169 (2012).
Deng, M. et al. Lepr(+) mesenchymal cells sense diet to modulate intestinal stem/progenitor cells via Leptin-Igf1 axis. Cell Res. https://doi.org/10.1038/s41422-022-00643-9 (2022).
Geng, L., Lam, K. S. L. & Xu, A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat. Rev. Endocrinol. 16, 654–667 (2020).
Yu, D. et al. The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. Cell Metab. 33, 905–922.e6 (2021).
Wei, S. et al. Intermittent protein restriction protects islet β cells and improves glucose homeostasis in diabetic mice. Sci. Bull. 67, 733–747 (2022).
Fontana, L. et al. Decreased consumption of branched-chain amino acids improves metabolic health. Cell Rep. 16, 520–530 (2016).
Hill, C. M. et al. FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male mice. Nat. Commun. 13, 1897 (2022).
Zhang, Y. et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife 1, e00065 (2012).
Collins, N. & Belkaid, Y. Control of immunity via nutritional interventions. Immunity 55, 210–223 (2022).
Ansaldo, E., Farley, T. K. & Belkaid, Y. Control of immunity by the microbiota. Annu Rev. Immunol. 39, 449–479 (2021).
Wu, Q. et al. YAP/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression. Biosci. Rep. 37, BSR20171072 (2017).
Weisberg, S. P., Ural, B. B. & Farber, D. L. Tissue-specific immunity for a changing world. Cell 184, 1517–1529 (2021).
Wu, Q., Yu, X., Li, J., Sun, S. & Tu, Y. Metabolic regulation in the immune response to cancer. Cancer Commun. (Lond.) 41, 661–694 (2021).
Geltink, R. I. K., Kyle, R. L. & Pearce, E. L. Unraveling the complex interplay between T cell metabolism and function. Annu Rev. Immunol. 36, 461–488 (2018).
Ma, E. H. et al. Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8(+) T cells. Immunity 51, 856–870.e5 (2019).
Palma, C. et al. Caloric restriction promotes immunometabolic reprogramming leading to protection from tuberculosis. Cell Metab. 33, 300–318.e12 (2021).
Collins, N. et al. The bone marrow protects and optimizes immunological memory during dietary restriction. Cell 178, 1088–1101.e15 (2019).
Jordan, S. et al. Dietary intake regulates the circulating inflammatory monocyte pool. Cell 178, 1102–1114.e17 (2019).
Wu, Z. et al. Dietary restriction extends lifespan through metabolic regulation of innate immunity. Cell Metab. 29, 1192–1205.e8 (2019).
Ma, S. et al. Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging. Cell 180, 984–1001.e22 (2020).
Xiao, Z. X. et al. High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways. Signal Transduct. Target Ther. 5, 34 (2020).
Ruck, T. et al. K(2P)18.1 translates T cell receptor signals into thymic regulatory T cell development. Cell Res. 32, 72–88 (2022).
Yao, Y. et al. Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat. Immunol. 22, 1127–1139 (2021).
Iovino, L. et al. Activation of the Zinc-sensing receptor GPR39 promotes T cell reconstitution after hematopoietic cell transplant in mice. Blood. https://doi.org/10.1182/blood.2021013950 (2022).
Zhang, H. et al. Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8(+) T-cell memory development. Nat. Cell Biol. 22, 18–25 (2020).
Cucchi, D. et al. Omega-3 polyunsaturated fatty acids impinge on CD4+ T cell motility and adipose tissue distribution via direct and lipid mediator-dependent effects. Cardiovasc. Res. 116, 1006–1020 (2020).
Zhang, H. et al. Polyamines control eIF5A hypusination, TFEB translation, and autophagy to reverse B cell senescence. Mol. Cell 76, 110–125 e9 (2019).
Beyaz, S. et al. Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis. Cell Stem. Cell 28, 1922–1935.e5 (2021).
Wilck, N. et al. Salt-responsive gut commensal modulates T(H)17 axis and disease. Nature 551, 585–589 (2017).
Rizvi, Z. A. et al. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci. Adv. 7, eabg5016 (2021).
Sepahi, A., Liu, Q., Friesen, L. & Kim, C. H. Dietary fiber metabolites regulate innate lymphoid cell responses. Mucosal. Immunol. 14, 317–330 (2021).
Alexander, M. & Turnbaugh, P. J. Deconstructing mechanisms of diet-microbiome-immune interactions. Immunity 53, 264–276 (2020).
von Schwartzenberg, R. J. et al. Caloric restriction disrupts the microbiota and colonization resistance. Nature 595, 272–277 (2021).
Fabbiano, S. et al. Functional gut microbiota remodeling contributes to the caloric restriction-induced metabolic improvements. Cell Metab. 28, 907–921.e7 (2018).
Li, M. et al. Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice. Nat. Commun. 13, 2060 (2022).
Bauer, P. V. et al. Lactobacillus gasseri in the upper small intestine impacts an ACSL3-dependent fatty acid-sensing pathway regulating whole-body glucose homeostasis. Cell Metab. 27, 572–587.e6 (2018).
Maifeld, A. et al. Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients. Nat. Commun. 12, 1970 (2021).
Sbierski-Kind, J. et al. Effects of caloric restriction on the gut microbiome are linked with immune senescence. Microbiome 10, 57 (2022).
Jian, C. et al. Gut microbiota predicts body fat change following a low-energy diet: a PREVIEW intervention study. Genome Med 14, 54 (2022).
Johnson, A. J. et al. Daily sampling reveals personalized diet-microbiome associations in humans. Cell Host Microbe 25, 789–802.e5 (2019).
Ang, Q. Y. et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17. Cells Cell 181, 1263–1275.e16 (2020).
Wastyk, H. C. et al. Gut-microbiota-targeted diets modulate human immune status. Cell 184, 4137–4153.e14 (2021).
Liu, H. et al. Ecological dynamics of the gut microbiome in response to dietary fiber. ISME J. https://doi.org/10.1038/s41396-022-01253-4 (2022).
Lancaster, S. M. et al. Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans. Cell Host Microbe 30, 848–862.e7 (2022).
Deehan, E. C. et al. Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell Host Microbe 27, 389–404.e6 (2020).
Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339–1353.e21 (2016).
Ke, W. et al. Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion. Nat. Commun. 11, 2587 (2020).
Zheng, D., Ratiner, K. & Elinav, E. Circadian influences of diet on the microbiome and immunity. Trends Immunol. 41, 512–530 (2020).
Choi, H., Rao, M. C. & Chang, E. B. Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism. Nat. Rev. Gastroenterol. Hepatol. 18, 679–689 (2021).
Tuganbaev, T. et al. Diet diurnally regulates small intestinal microbiome-epithelial-immune homeostasis and enteritis. Cell 182, 1441–1459.e21 (2020).
Wiley, C. D. & Campisi, J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat. Metab. 3, 1290–1301 (2021).
Di Micco, R., Krizhanovsky, V., Baker, D. & d’Adda di Fagagna, F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75–95 (2021).
Fontana, L. et al. The effects of graded caloric restriction: XII. Comparison of mouse to human impact on cellular senescence in the colon. Aging Cell 17, e12746 (2018).
Roberts, M. N. et al. A ketogenic diet extends longevity and healthspan in adult mice. Cell Metab. 26, 539–546.e5 (2017).
Parkhitko, A. A. et al. A genetic model of methionine restriction extends Drosophila health- and lifespan. Proc. Natl Acad. Sci. USA 118, e2110387118 (2021).
Han, Y. M. et al. β-Hydroxybutyrate prevents vascular senescence through hnRNP A1-mediated upregulation of Oct4. Mol. Cell 71, 1064–1078.e5 (2018).
Gao, X. et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature 572, 397–401 (2019).
Koyama, T. et al. A nutrient-responsive hormonal circuit mediates an inter-tissue program regulating metabolic homeostasis in adult Drosophila. Nat. Commun. 12, 5178 (2021).
Buchanan, K. L. et al. The preference for sugar over sweetener depends on a gut sensor cell. Nat. Neurosci. 25, 191–200 (2022).
Lin, H. H. et al. A nutrient-specific gut hormone arbitrates between courtship and feeding. Nature 602, 632–638 (2022).
Witte, A. V., Fobker, M., Gellner, R., Knecht, S. & Flöel, A. Caloric restriction improves memory in elderly humans. Proc. Natl Acad. Sci. USA 106, 1255–1260 (2009).
Bondolfi, L., Ermini, F., Long, J. M., Ingram, D. K. & Jucker, M. Impact of age and caloric restriction on neurogenesis in the dentate gyrus of C57BL/6 mice. Neurobiol. Aging 25, 333–340 (2004).
Luo, J., Daniels, S. B., Lennington, J. B., Notti, R. Q. & Conover, J. C. The aging neurogenic subventricular zone. Aging Cell 5, 139–152 (2006).
Lee, J., Seroogy, K. B. & Mattson, M. P. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J. Neurochem 80, 539–547 (2002).
Encinas, J. M. et al. Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus. Cell Stem Cell 8, 566–579 (2011).
Liu, X. et al. Calorie restriction and calorie dilution have different impacts on body fat, metabolism, behavior, and hypothalamic gene expression. Cell Rep. 39, 110835 (2022).
Wu, Y. et al. Very-low-protein diets lead to reduced food intake and weight loss, linked to inhibition of hypothalamic mTOR signaling, in mice. Cell Metab. 33, 888–904.e6 (2021).
Fortier, M. et al. A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT. Alzheimers Dement 17, 543–552 (2021).
Ren, B. et al. Methionine restriction alleviates age-associated cognitive decline via fibroblast growth factor 21. Redox Biol. 41, 101940 (2021).
Viskaitis, P. et al. Ingested non-essential amino acids recruit brain orexin cells to suppress eating in mice. Curr. Biol. 32, 1812–1821.e4 (2022).
Larabee, C. M., Neely, O. C. & Domingos, A. I. Obesity: a neuroimmunometabolic perspective. Nat. Rev. Endocrinol. 16, 30–43 (2020).
Simonson, M., Boirie, Y. & Guillet, C. Protein, amino acids and obesity treatment. Rev. Endocr. Metab. Disord. 21, 341–353 (2020).
Choi, B. S. et al. Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice. Nat. Commun. 12, 3377 (2021).
Liu, K. H. et al. Microbial metabolite delta-valerobetaine is a diet-dependent obesogen. Nat. Metab. 3, 1694–1705 (2021).
Fabbiano, S. et al. Caloric restriction leads to browning of white adipose tissue through type 2 immune signaling. Cell Metab. 24, 434–446 (2016).
Miller, K. N. et al. Aging and caloric restriction impact adipose tissue, adiponectin, and circulating lipids. Aging Cell 16, 497–507 (2017).
Dorling, J. L. et al. Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. Eur. J. Nutr. 60, 1633–1643 (2021).
Kim, K. H. et al. Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage. Cell Res. 27, 1309–1326 (2017).
Brandhorst, S. et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab. 22, 86–99 (2015).
Pak, H. H. et al. Fasting drives the metabolic, molecular and geroprotective effects of a calorie-restricted diet in mice. Nat. Metab. 3, 1327–1341 (2021).
Cienfuegos, S. et al. Effects of 4- and 6-h time-restricted feeding on weight and cardiometabolic health: a randomized controlled trial in adults with obesity. Cell Metab. 32, 366–378.e3 (2020).
Wilkinson, M. J. et al. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metab. 31, 92–104.e5 (2020).
Harney, D. J. et al. Proteomics analysis of adipose depots after intermittent fasting reveals visceral fat preservation mechanisms. Cell Rep. 34, 108804 (2021).
Li, G. et al. Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota. Cell Metab. 26, 672–685.e4 (2017).
Liu, D. et al. Calorie restriction with or without time-restricted eating in weight loss. N. Engl. J. Med. 386, 1495–1504 (2022).
Wang, F. et al. Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes. Diabetologia 65, 1119–1132 (2022).
Meslier, V. et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut 69, 1258–1268 (2020).
Ma, Q. X. et al. BCAA-BCKA axis regulates WAT browning through acetylation of PRDM16. Nat. Metab. 4, 106–122 (2022).
Mocanu, V. et al. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat. Med. 27, 1272–1279 (2021).
Daniel, N. et al. Gut microbiota and fermentation-derived branched chain hydroxy acids mediate health benefits of yogurt consumption in obese mice. Nat. Commun. 13, 1343 (2022).
Rodriguez, J. et al. Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals. BMC Med. 20, 110 (2022).
Katsumura, S. et al. Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure. Cell Metab. 34, 564–580.e8 (2022).
Sciarretta, S. et al. Caloric restriction mimetics for the treatment of cardiovascular diseases. Cardiovasc Res. 117, 1434–1449 (2021).
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R. & Abel, E. D. Cardiac energy metabolism in heart failure. Circ. Res. 128, 1487–1513 (2021).
Xu, Y. et al. Branched-chain amino acid catabolism promotes thrombosis risk by enhancing tropomodulin-3 propionylation in platelets. Circulation 142, 49–64 (2020).
Redman, L. M. et al. Metabolic slowing and reduced oxidative damage with sustained caloric restriction support the rate of living and oxidative damage theories of aging. Cell Metab. 27, 805–815 e4 (2018).
Sloan, C. et al. Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice. Diabetes 60, 1424–1434 (2011).
An, H. S. et al. Caloric restriction reverses left ventricular hypertrophy through the regulation of cardiac iron homeostasis in impaired leptin signaling mice. Sci. Rep. 10, 7176 (2020).
Bhanpuri, N. H. et al. Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. Cardiovasc Diabetol. 17, 56 (2018).
Wei, M. et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci. Transl. Med. 9, eaai8700 (2017).
Mishra, A. et al. Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan. Nat. Metab. 3, 1342–1356 (2021).
Shi, H. et al. Restructuring the gut microbiota by intermittent fasting lowers blood pressure. Circ. Res. 128, 1240–1254 (2021).
Marques, F. Z. et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 135, 964–977 (2017).
Weis, E. M. et al. Ketone body oxidation increases cardiac endothelial cell proliferation. EMBO Mol. Med. 14, e14753 (2022).
Rinott, E. et al. The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial. Genome Med. 14, 29 (2022).
Wang, D. D. et al. The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk. Nat. Med. 27, 333–343 (2021).
Delgado-Lista, J. et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet 399, 1876–1885 (2022).
Jimenez-Torres, J. et al. Mediterranean diet reduces atherosclerosis progression in coronary heart disease: an analysis of the CORDIOPREV randomized controlled trial. Stroke 52, 3440–3449 (2021).
Zaramela, L. S. et al. Gut bacteria responding to dietary change encode sialidases that exhibit preference for red meat-associated carbohydrates. Nat. Microbiol. 4, 2082–2089 (2019).
Schwärzler, J. et al. PUFA-induced metabolic enteritis as a fuel for Crohn’s disease. Gastroenterology 162, 1690–1704 (2022).
Akagi, K. et al. Dietary restriction improves intestinal cellular fitness to enhance gut barrier function and lifespan in D. melanogaster. PLoS Genet. 14, e1007777 (2018).
Luis, N. M. et al. Intestinal IRE1 is required for increased triglyceride metabolism and longer lifespan under dietary restriction. Cell Rep. 17, 1207–1216 (2016).
Gelino, S. et al. Intestinal autophagy improves healthspan and longevity in C. elegans during dietary restriction. PLoS Genet. 12, e1006135 (2016).
Prince, A. C. et al. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory Bowel disease. Inflamm. Bowel Dis. 22, 1129–1136 (2016).
Fritsch, J. et al. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin. Gastroenterol. Hepatol. 19, 1189–1199.e30 (2021).
Kong, C. et al. Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome. Signal Transduct. Target Ther. 6, 154 (2021).
Kitamoto, S. et al. Dietary L-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut. Nat. Microbiol. 5, 116–125 (2020).
Lobel, L., Cao, Y. G., Fenn, K., Glickman, J. N. & Garrett, W. S. Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function. Science 369, 1518–1524 (2020).
Wilck, N., Balogh, A., Markó, L., Bartolomaeus, H. & Müller, D. N. The role of sodium in modulating immune cell function. Nat. Rev. Nephrol. 15, 546–558 (2019).
Lee, H. W. et al. Effect of dietary protein restriction on renal ammonia metabolism. Am. J. Physiol. Ren. Physiol. 308, F1463–F1473 (2015).
Yacoub, R. et al. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS ONE 12, e0184789 (2017).
Fang, Y. et al. The ketone body β-hydroxybutyrate mitigates the senescence response of glomerular podocytes to diabetic insults. Kidney Int 100, 1037–1053 (2021).
Yamamoto, T. et al. Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux. Autophagy 17, 1700–1713 (2021).
Podadera-Herreros, A. et al. Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: the CORDIOPREV randomized controlled trial. Clin. Nutr. 41, 552–559 (2022).
Gräff, J. et al. A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration. J. Neurosci. 33, 8951–8960 (2013).
Bendlin, B. B. et al. Effects of aging and calorie restriction on white matter in rhesus macaques. Neurobiol. Aging 32, 2319.e1–11 (2011).
Newman, J. C. et al. Ketogenic diet reduces midlife mortality and improves memory in aging mice. Cell Metab. 26, 547–557.e8 (2017).
Rojic-Becker, D., Portero-Tresserra, M., Martí-Nicolovius, M., Vale-Martínez, A. & Guillazo-Blanch, G. Caloric restriction modulates the monoaminergic and glutamatergic systems in the hippocampus, and attenuates age-dependent spatial memory decline. Neurobiol. Learn Mem. 166, 107107 (2019).
Shruthi, K. et al. Amelioration of neuronal cell death in a spontaneous obese rat model by dietary restriction through modulation of ubiquitin proteasome system. J. Nutr. Biochem. 33, 73–81 (2016).
Vermeij, W. P. et al. Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature 537, 427–431 (2016).
Duan, W. et al. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl Acad. Sci. USA 100, 2911–2916 (2003).
Liang, Y. et al. eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction. Cell Rep. 35, 108941 (2021).
Liu, X. et al. High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. Cell Metab. 33, 923–938.e6 (2021).
Fontana, L., Ghezzi, L., Cross, A. H. & Piccio, L. Effects of dietary restriction on neuroinflammation in neurodegenerative diseases. J. Exp. Med. 218, e20190086 (2021).
Zhou, Z. L. et al. Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson’s disease mice via gut microbiota and metabolites. Neurotherapeutics 16, 741–760 (2019).
Brakedal, B. et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metab. 34, 396–407.e6 (2022).
Bredesen, D. E. et al. Reversal of cognitive decline in Alzheimer’s disease. Aging 8, 1250–1258 (2016).
Tomi, M., Zhao, Y., Thamotharan, S., Shin, B. C. & Devaskar, S. U. Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer’s disease with aging. Brain Res. 1495, 61–75 (2013).
Mutoh, T. et al. Impact of medium-chain triglycerides on gait performance and brain metabolic network in healthy older adults: a double-blind, randomized controlled study. Geroscience. https://doi.org/10.1007/s11357-022-00553-z (2022).
Ghosh, T. S. et al. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 69, 1218–1228 (2020).
Moreno, C. L., Ehrlich, M. E. & Mobbs, C. V. Protection by dietary restriction in the YAC128 mouse model of Huntington’s disease: Relation to genes regulating histone acetylation and HTT. Neurobiol. Dis. 85, 25–34 (2016).
Wang, H. B. et al. Time-restricted feeding improves circadian dysfunction as well as motor symptoms in the Q175 mouse model of Huntington’s disease. eNeuro 5, ENEURO.0431–17.2017 (2018).
Mattison, J. A. et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489, 318–321 (2012).
Ham, D. J. et al. Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle. Nat. Commun. 13, 2025 (2022).
Gutiérrez-Casado, E. et al. The impact of aging, calorie restriction and dietary fat on autophagy markers and mitochondrial ultrastructure and dynamics in mouse skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci. 74, 760–769 (2019).
Marzetti, E. et al. Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech. Ageing Dev. 130, 272–280 (2009).
Jang, Y. C. et al. Dietary restriction attenuates age-associated muscle atrophy by lowering oxidative stress in mice even in complete absence of CuZnSOD. Aging Cell 11, 770–782 (2012).
Hepple, R. T., Qin, M., Nakamoto, H. & Goto, S. Caloric restriction optimizes the proteasome pathway with aging in rat plantaris muscle: implications for sarcopenia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1231–R1237 (2008).
van Norren, K. et al. Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice. J. Cachexia Sarcopenia Muscle 6, 253–268 (2015).
McKiernan, S. H. et al. Caloric restriction delays aging-induced cellular phenotypes in rhesus monkey skeletal muscle. Exp. Gerontol. 46, 23–29 (2011).
Burks, T. N. & Cohn, R. D. One size may not fit all: anti-aging therapies and sarcopenia. Aging 3, 1142–1153 (2011).
Benjamin, D. I. et al. Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling. Cell Metab. 34, 902–918.e6 (2022).
Aoyama, S. et al. Distribution of dietary protein intake in daily meals influences skeletal muscle hypertrophy via the muscle clock. Cell Rep. 36, 109336 (2021).
Villareal, D. T. et al. Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial. J. Bone Min. Res. 31, 40–51 (2016).
Bodnar, M., Skalicky, M., Viidik, A. & Erben, R. G. Interaction between exercise, dietary restriction and age-related bone loss in a rodent model of male senile osteoporosis. Gerontology 58, 139–149 (2012).
Cao, J. J. Caloric restriction combined with exercise is effective in reducing adiposity and mitigating bone structural deterioration in obese rats. Ann. N. Y Acad. Sci. 1433, 41–52 (2018).
Huang, T. H. & Ables, G. P. Dietary restrictions, bone density, and bone quality. Ann. N. Y Acad. Sci. 1363, 26–39 (2016).
Trivedi, A., Babic, S., Heiman, M., Gibson, W. T. & Chanoine, J. P. Ghrelin, ghrelin o-acyltransferase, and carbohydrate metabolism during pregnancy in calorie-restricted mice. Horm. Metab. Res. 49, 64–72 (2017).
Molon-Noblot, S., Laroque, P., Coleman, J. B., Hoe, C. M. & Keenan, K. P. The effects of ad libitum overfeeding and moderate and marked dietary restriction on age-related spontaneous pituitary gland pathology in Sprague-Dawley rats. Toxicol. Pathol. 31, 310–320 (2003).
Bédard, K., Bédard, J., Rocheleau, G., Ferland, G. & Gaudreau, P. Aging and diets regulate the rat anterior pituitary and hypothalamic transcriptome. Neuroendocrinology 97, 146–159 (2013).
Qiu, G. et al. Neuroprotection provided by dietary restriction in rats is further enhanced by reducing glucocortocoids. Neurobiol. Aging 33, 2398–2410 (2012).
Tabrizi, F. P. F., Farhangi, M. A., Vaezi, M. & Hemmati, S. The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Nutr. J. 19, 82 (2020).
Schulte, D. M. et al. Caloric restriction increases serum testosterone concentrations in obese male subjects by two distinct mechanisms. Horm. Metab. Res. 46, 283–286 (2014).
Minakhina, S., De Oliveira, V., Kim, S. Y., Zheng, H. & Wondisford, F. E. Thyroid hormone receptor phosphorylation regulates acute fasting-induced suppression of the hypothalamic-pituitary-thyroid axis. Proc. Natl Acad. Sci. USA 118, e2107943118 (2021).
Puyskens, A. et al. Aryl hydrocarbon receptor modulation by tuberculosis drugs impairs host defense and treatment outcomes. Cell Host Microbe 27, 238–248.e7 (2020).
McDonald, V. M. et al. Should we treat obesity in COPD? The effects of diet and resistance exercise training. Respirology 21, 875–882 (2016).
Rubini, A. et al. Effects of twenty days of the ketogenic diet on metabolic and respiratory parameters in healthy subjects. Lung 193, 939–945 (2015).
Goldberg, E. L. et al. Ketogenic diet activates protective γδ T cell responses against influenza virus infection. Sci. Immunol. 4, eaav2026 (2019).
Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159–166 (2014).
Trompette, A. et al. Dietary fiber confers protection against flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism. Immunity 48, 992–1005.e8 (2018).
Das, M. et al. Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models. Nat. Commun. 12, 565 (2021).
Ajona, D. et al. Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade. Nat. Cancer 1, 75–85 (2020).
Ma, D. et al. Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth. Oncogene 37, 1041–1048 (2018).
de Cabo, R. et al. Serum from calorie-restricted animals delays senescence and extends the lifespan of normal human fibroblasts in vitro. Aging 7, 152–166 (2015).
Wu, Q. et al. Exosomes from the tumour-adipocyte interplay stimulate beige/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression. J. Exp. Clin. Cancer Res. 38, 223 (2019).
Gouirand, V. et al. Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. EMBO J. 41, e110466 (2022).
Xia, S. et al. Prevention of dietary-fat-fueled ketogenesis attenuates BRAF V600E tumor growth. Cell Metab. 25, 358–373 (2017).
Voss, M. et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. Eur. J. Nutr. 61, 477–487 (2022).
Dierge, E. et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 33, 1701–1715.e5 (2021).
Lien, E. C. et al. Low glycaemic diets alter lipid metabolism to influence tumour growth. Nature 599, 302–307 (2021).
Maddocks, O. D. K. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544, 372–376 (2017).
Cramer, S. L. et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat. Med 23, 120–127 (2017).
Badgley, M. A. et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science 368, 85–89 (2020).
Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013–1021 (2019).
Vernieri, C. et al. Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer. Cancer Disco. 12, 90–107 (2022).
Rubio-Patino, C. et al. Low-protein diet induces IRE1alpha-dependent anticancer immunosurveillance. Cell Metab. 27, 828–842 e7 (2018).
Eil, R. et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature 537, 539–543 (2016).
Yilmaz, O. H. Dietary regulation of the origins of cancer. Sci. Transl. Med. 10, eaat8285 (2018).
de Groot, S. et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat. Commun. 11, 3083 (2020).
Di Biase, S. et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell 30, 136–146 (2016).
Yang, L. et al. Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. Med 3, 119–136.e8 (2022).
Wu, J. et al. Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS. Signal Transduct. Target Ther. 6, 188 (2021).
Krstic, J. et al. Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism. Sci. Adv. 8, eabh2635 (2022).
Dmitrieva-Posocco, O. et al. β-Hydroxybutyrate suppresses colorectal cancer. Nature 605, 160–165 (2022).
Ferrere, G. et al. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade. JCI Insight 6, e145207 (2021).
Hirschberger, S. et al. Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming. EMBO Mol. Med 13, e14323 (2021).
Yang, J. J. et al. Association of dietary fiber and yogurt consumption with lung cancer risk: a pooled analysis. JAMA Oncol. 6, e194107 (2020).
Spencer, C. N. et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374, 1632–1640 (2021).
Dizman, N. et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat. Med. 28, 704–712 (2022).
Luu, M. et al. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat. Commun. 12, 4077 (2021).
Coutzac, C. et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat. Commun. 11, 2168 (2020).
Wang, Y. et al. NAD(+) supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells. Cell Rep. 36, 109516 (2021).
Lv, H. et al. NAD(+) metabolism maintains inducible PD-L1 expression to drive tumor immune evasion. Cell Metab. 33, 110–127.e5 (2021).
Vodnala, S. K. et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 363, eaau0135 (2019).
Havula, E. et al. Genetic variation of macronutrient tolerance in Drosophila melanogaster. Nat. Commun. 13, 1637 (2022).
Mitchell, S. J. et al. Daily fasting improves health and survival in male mice independent of diet composition and calories. Cell Metab. 29, 221–228.e3 (2019).
Green, C. L. et al. Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction. Cell Metab. 34, 209–226.e5 (2022).
Granger, B. Some account of the fasting-woman at titbury. Edinb. Med. Surg. J. 5, 319–326 (1809).
Rous, P. The influence of diet on transplanted and spontaneous mouse tumors. J. Exp. Med. 20, 433–451 (1914).
Kiehm, T. G., Anderson, J. W. & Ward, K. Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men. Am. J. Clin. Nutr. 29, 895–899 (1976).
Finzi, M. Fermented milks (yogurt) in the diet therapy of chronic constipation. Minerva Med. 57, varia 979+ (1966).
Ferro-Luzzi, A. et al. Changing the Mediterranean diet: effects on blood lipids. Am. J. Clin. Nutr. 40, 1027–1037 (1984).
Stoltzner, G. Effects of life-long dietary protein restriction on mortality, growth, organ weights, blood counts, liver aldolase and kidney catalase in Balb/C mice. Growth 41, 337–348 (1977).
Wilder, R. J. The effects of ketonemia on the course of epilepsy. Mayo Clinic Proceedings 2, 307–308 (1921).
Rollo, J. Account of two cases of diabetes mellitus, with remarks. Ann. Med. 2, 85–105 (1797).
AMINO acid imbalance and supplementation. J. Am. Med. Assoc. 161, 884–885 (1956).
Steenbock, H. Vitamines and nutrition. Science 47, 119 (1918).
Salmon, W. D. The effect of mineral supplements on growth and reproduction. Science 60, 457 (1924).
Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177–189 (2002).
Sim, A. T. & Hardie, D. G. The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett. 233, 294–298 (1988).
Costa, R. H., Grayson, D. R. & Darnell, J. E. Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol. Cell Biol. 9, 1415–1425 (1989).
Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800 (2000).
Honjoh, S., Yamamoto, T., Uno, M. & Nishida, E. Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C. elegans. Nature 457, 726–730 (2009).
Catterson, J. H. et al. Short-term, intermittent fasting induces long-lasting gut health and TOR-independent lifespan extension. Curr. Biol. 28, 1714–1724.e4 (2018).
Kaeberlein, M. et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310, 1193–1196 (2005).
Hansen, M. et al. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet. 4, e24 (2008).
Weng, M., Golden, K. L. & Lee, C. Y. dFezf/Earmuff maintains the restricted developmental potential of intermediate neural progenitors in Drosophila. Dev. Cell 18, 126–135 (2010).
Bonawitz, N. D., Chatenay-Lapointe, M., Pan, Y. & Shadel, G. S. Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression. Cell Metab. 5, 265–277 (2007).
Jensen, K., McClure, C., Priest, N. K. & Hunt, J. Sex-specific effects of protein and carbohydrate intake on reproduction but not lifespan in Drosophila melanogaster. Aging Cell 14, 605–615 (2015).
Lee, K. P. et al. Lifespan and reproduction in Drosophila: New insights from nutritional geometry. Proc. Natl Acad. Sci. USA 105, 2498–2503 (2008).
Stefana, M. I. et al. Developmental diet regulates Drosophila lifespan via lipid autotoxins. Nat. Commun. 8, 1384 (2017).
Fanson, B. G., Weldon, C. W., Pérez-Staples, D., Simpson, S. J. & Taylor, P. W. Nutrients, not caloric restriction, extend lifespan in Queensland fruit flies (Bactrocera tryoni). Aging Cell 8, 514–523 (2009).
Solon-Biet, S. M. et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 19, 418–430 (2014).
Powers, R. W. 3rd, Kaeberlein, M., Caldwell, S. D., Kennedy, B. K. & Fields, S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20, 174–184 (2006).
Lee, B. C. et al. Methionine restriction extends lifespan of Drosophila melanogaster under conditions of low amino-acid status. Nat. Commun. 5, 3592 (2014).
Ruckenstuhl, C. et al. Lifespan extension by methionine restriction requires autophagy-dependent vacuolar acidification. PLoS Genet. 10, e1004347 (2014).
Lu, J. et al. Sestrin is a key regulator of stem cell function and lifespan in response to dietary amino acids. Nat. Aging 1, 60–72 (2021).
Brown-Borg, H. M. et al. Growth hormone signaling is necessary for lifespan extension by dietary methionine. Aging Cell 13, 1019–1027 (2014).
Miller, R. A. et al. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 4, 119–125 (2005).
Zimmerman, J. A., Malloy, V., Krajcik, R. & Orentreich, N. Nutritional control of aging. Exp. Gerontol. 38, 47–52 (2003).
Sanz, A. et al. Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins. FASEB J. 20, 1064–1073 (2006).
Sasikumar, A. N., Killilea, D. W., Kennedy, B. K. & Brem, R. B. Potassium restriction boosts vacuolar acidity and extends lifespan in yeast. Exp. Gerontol. 120, 101–106 (2019).
Klang, I. M. et al. Iron promotes protein insolubility and aging in C. elegans. Aging 6, 975–991 (2014).
Kumar, J. et al. Zinc levels modulate lifespan through multiple longevity pathways in Caenorhabditis elegans. PLoS ONE 11, e0153513 (2016).
Cohen, K. et al. Caloric restriction ameliorates cardiomyopathy in animal model of diabetes. Exp. Cell Res. 350, 147–153 (2017).
Kanda, Y. et al. Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice. J. Nutr. Biochem. 26, 219–226 (2015).
Waldman, M. et al. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’. Cardiovasc. Diabetol. 17, 111 (2018).
Baumeier, C. et al. Caloric restriction and intermittent fasting alter hepatic lipid droplet proteome and diacylglycerol species and prevent diabetes in NZO mice. Biochim. Biophys. Acta 1851, 566–576 (2015).
Castaño-Martinez, T. et al. Methionine restriction prevents onset of type 2 diabetes in NZO mice. FASEB J. 33, 7092–7102 (2019).
Shibolet, O., Alper, R., Avraham, Y., Berry, E. M. & Ilan, Y. Immunomodulation of experimental colitis via caloric restriction: role of Nk1.1+ T cells. Clin. Immunol. 105, 48–56 (2002).
Liu, G. et al. Methionine restriction on oxidative stress and immune response in dss-induced colitis mice. Oncotarget 8, 44511–44520 (2017).
Robertson, L. T. et al. Protein and calorie restriction contribute additively to protection from renal ischemia reperfusion injury partly via leptin reduction in male mice. J. Nutr. 145, 1717–1727 (2015).
Shushimita, S. et al. Mannan-binding lectin is involved in the protection against renal ischemia/reperfusion injury by dietary restriction. PLoS ONE 10, e0137795 (2015).
Shin, B. K., Kang, S., Kim, D. S. & Park, S. Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer’s disease-induced estrogen deficient rats. Exp. Biol. Med. 243, 334–343 (2018).
Liu, Y. et al. SIRT3 mediates hippocampal synaptic adaptations to intermittent fasting and ameliorates deficits in APP mutant mice. Nat. Commun. 10, 1886 (2019).
Lazic, D. et al. Every-other-day feeding exacerbates inflammation and neuronal deficits in 5XFAD mouse model of Alzheimer’s disease. Neurobiol. Dis. 136, 104745 (2020).
Sharp, Z. D. et al. Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice. Carcinogenesis 24, 179–183 (2003).
Sundaram, S. & Yan, L. Dietary energy restriction reduces high-fat diet-enhanced metastasis of Lewis lung carcinoma in mice. Oncotarget 7, 65669–65675 (2016).
Simone, B. A. et al. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model. Cell Cycle 17, 1536–1544 (2018).
Fontana, L. et al. Dietary protein restriction inhibits tumor growth in human xenograft models. Oncotarget 4, 2451–2461 (2013).
Orillion, A. et al. Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy. Clin. Cancer Res. 24, 6383–6395 (2018).
Ma, E. H. et al. Serine is an essential metabolite for effector T cell expansion. Cell Metab. 25, 345–357 (2017).
Maddocks, O. D., Labuschagne, C. F., Adams, P. D. & Vousden, K. H. Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol. Cell 61, 210–221 (2016).
Sullivan, M. R. et al. Increased serine synthesis provides an advantage for tumors arising in tissues where serine levels are limiting. Cell Metab. 29, 1410–1421.e4 (2019).
Golbourn, B. J. et al. Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome. Nat. Cancer 3, 629–648 (2022).
Poillet-Perez, L. et al. Autophagy maintains tumour growth through circulating arginine. Nature 563, 569–573 (2018).
Geiger, R. et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167, 829–842.e13 (2016).
Li, J. T. et al. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma. Nat. Cell Biol. 22, 167–174 (2020).
Thandapani, P. et al. Valine tRNA levels and availability regulate complex I assembly in leukaemia. Nature 601, 428–433 (2022).
Gottschalk Højfeldt, S. et al. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia. Blood 137, 2373–2382 (2021).
Wise (formerly TransferWise) is the cheaper, easier way to send money abroad. It helps people move money quickly and easily between bank accounts in different countries. Convert 60+ currencies with ridiculously low fees - on average 7x cheaper than a bank. No hidden fees, no markup on the exchange rate, ever.
How to access the offer?
1- Click here
2- Select “Register''
3- Enter your email address, create a password, and select your country of residence
4- Fill out the required personal information, and the free first transfer offer will be applied automatically.
Benefits of the Multi-Currency Account:
- Free to create online
- Hold 50+ currencies
- Get multiple local bank details in one account (including EU, UK, US)
- Convert currency at the real exchange rate, even on weekends
- Spend whilst travelling on the Wise debit card without high conversion fees
Wise International Transfers:
- $1.5 billion saved by customers every year
- Send money to over 60 target currencies
- Lower fees for larger transfers
- No hidden fees. No bad exchange rates. No surprises.
- Send your money with a bank transfer, or a debit or credit card